A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

  Subjects -> PHARMACY AND PHARMACOLOGY (Total: 575 journals)
The end of the list has been reached or no journals were found for your choice.
Similar Journals
Journal Cover
Expert Review of Pharmacoeconomics & Outcomes Research
Journal Prestige (SJR): 0.738
Citation Impact (citeScore): 2
Number of Followers: 8  
 
  Full-text available via subscription Subscription journal
ISSN (Print) 1473-7167 - ISSN (Online) 1744-8379
Published by Taylor and Francis Homepage  [2648 journals]
  • Indirect treatment comparison and cost-minimization analysis of riociguat
           versus selexipag in patients with pulmonary arterial hypertension

    • Free pre-print version: Loading...

      Authors: Eva Ornstová, Jan Tužil, Kateřina Chadimová, Tomáš Mlčoch, Tomáš Doležal
      Pages: 1 - 7
      Abstract: .

      Citation: Expert Review of Pharmacoeconomics & Outcomes Research
      PubDate: 2022-09-27T07:21:55Z
      DOI: 10.1080/14737167.2022.2126833
       
  • Burden of disease of chronic pain in Colombia

    • Free pre-print version: Loading...

      Authors: Pieralessandro Lasalvia, Yaneth Gil-Rojas, Diego Rosselli
      Pages: 1 - 7
      Abstract: .

      Citation: Expert Review of Pharmacoeconomics & Outcomes Research
      PubDate: 2022-09-26T06:22:05Z
      DOI: 10.1080/14737167.2022.2125872
       
  • A systematic review of health state utility values in Thai cancer patients

    • Free pre-print version: Loading...

      Authors: Krittaphas Kangwanrattanakul
      Pages: 1 - 16
      Abstract: .

      Citation: Expert Review of Pharmacoeconomics & Outcomes Research
      PubDate: 2022-09-26T02:00:32Z
      DOI: 10.1080/14737167.2022.2123796
       
  • The impact of fibrodysplasia ossificans progressiva (FOP) on patients and
           their family members: results from an international burden of illness
           survey

         This is an Open Access Article Open Access Article

    • Free pre-print version: Loading...

      Authors: Mona Al Mukaddam, Katherine S. Toder, Michelle Davis, Amanda Cali, Moira Liljesthröm, Suzanne Hollywood, Kim Croskery, Anne-Sophie Grandoulier, Elaine A. Böing, John D. Whalen, Frederick S. Kaplan
      Pages: 1 - 15
      Abstract: .

      Citation: Expert Review of Pharmacoeconomics & Outcomes Research
      PubDate: 2022-09-21T07:47:36Z
      DOI: 10.1080/14737167.2022.2115360
       
  • Evaluating reporting of patient-reported outcomes in peptic ulcer disease:
           a meta-epidemiological study of randomized controlled trials

    • Free pre-print version: Loading...

      Authors: Reece M. Anderson, Sam Streck, Griffin Hughes, Bethany Sutterfield, Micah Kee, Audrey Wise, Cody Hillman, Ryan Ottwell, Micah Hartwell, Matt Vassar
      Pages: 1 - 8
      Abstract: .

      Citation: Expert Review of Pharmacoeconomics & Outcomes Research
      PubDate: 2022-09-13T06:19:59Z
      DOI: 10.1080/14737167.2022.2122955
       
  • Consumption of antidepressants and economic austerity in Brazil

    • Free pre-print version: Loading...

      Authors: Lívia Teixeira de Mattos, Claudia Garcia Serpa Osorio-de-Castro, Cláudia Du Bocage Santos-Pinto, Björn Wettermark, Carla Lourenço Tavares de Andrade
      Pages: 1 - 9
      Abstract: .

      Citation: Expert Review of Pharmacoeconomics & Outcomes Research
      PubDate: 2022-09-06T06:09:05Z
      DOI: 10.1080/14737167.2022.2117691
       
  • The economic burden of biologic disease-modifying antirheumatic drugs in
           rheumatoid arthritis patients in the United States

    • Free pre-print version: Loading...

      Authors: Qian Ding, Dane Shiltz, Dana Hossami, Alison M Konieczny
      Pages: 1 - 11
      Abstract: .

      Citation: Expert Review of Pharmacoeconomics & Outcomes Research
      PubDate: 2022-09-06T02:20:44Z
      DOI: 10.1080/14737167.2022.2117690
       
  • Design and testing of a health economic Markov model for treatment of
           anorexia nervosa

         This is an Open Access Article Open Access Article

    • Free pre-print version: Loading...

      Authors: Vegard G Svendsen, Joran Lokkerbol, Unna N Danner, Alberte Jansingh, Silvia MAA Evers, Ben FM Wijnen
      Pages: 1 - 9
      Abstract: .

      Citation: Expert Review of Pharmacoeconomics & Outcomes Research
      PubDate: 2022-09-02T06:21:58Z
      DOI: 10.1080/14737167.2022.2119130
       
  • Value assessment of new interventions for Alzheimer’s disease dementia
           in Japan based on literature review and group interview

         This is an Open Access Article Open Access Article

    • Free pre-print version: Loading...

      Authors: Ataru Igarashi, Shunya Ikeda
      Pages: 1 - 8
      Abstract: .

      Citation: Expert Review of Pharmacoeconomics & Outcomes Research
      PubDate: 2022-09-02T06:05:46Z
      DOI: 10.1080/14737167.2022.2118113
       
  • Burden of ischemic heart disease in Spain: incidence, hospital mortality
           and costs of hospital care

    • Free pre-print version: Loading...

      Authors: Josep Darbà, Alicia Marsà
      Pages: 1 - 6
      Abstract: .

      Citation: Expert Review of Pharmacoeconomics & Outcomes Research
      PubDate: 2022-08-25T06:48:50Z
      DOI: 10.1080/14737167.2022.2108794
       
  • A scoping review on patient heterogeneity in economic evaluations of
           precision medicine based on basket trials

    • Free pre-print version: Loading...

      Authors: Marzieh Nosrati, Shekoufeh Nikfar, Mandana Hasanzad
      Pages: 1 - 10
      Abstract: .

      Citation: Expert Review of Pharmacoeconomics & Outcomes Research
      PubDate: 2022-08-19T08:10:25Z
      DOI: 10.1080/14737167.2022.2108408
       
  • Normative data and socio-demographic determinants of the dermatology life
           quality index in a large online sample of the Hungarian population

    • Free pre-print version: Loading...

      Authors: Z. Beretzky, F. Rencz, V. Brodszky
      Pages: 1 - 9
      Abstract: .

      Citation: Expert Review of Pharmacoeconomics & Outcomes Research
      PubDate: 2022-08-08T07:40:35Z
      DOI: 10.1080/14737167.2022.2108793
       
  • Work productivity among patients with metastatic breast cancer in the
           United States

    • Free pre-print version: Loading...

      Authors: Sneha Durgapal, Kent Hanson, Samantha K Kurosky, Sharon Kautz, Steve Sison, Christina Cool
      Pages: 1 - 9
      Abstract: .

      Citation: Expert Review of Pharmacoeconomics & Outcomes Research
      PubDate: 2022-08-04T07:17:44Z
      DOI: 10.1080/14737167.2022.2108409
       
  • Determination of the economically justifiable price of cenobamate in the
           treatment of focal-onset seizures in adult patients with drug-resistant
           epilepsy in Spain

         This is an Open Access Article Open Access Article

    • Free pre-print version: Loading...

      Authors: Miguel Ángel Calleja, Andrés Navarro, José María Serratosa, Manuel Toledo, Vicente Villanueva, Silvia Subías Labazuy, Alicia Gil
      Pages: 1 - 10
      Abstract: .

      Citation: Expert Review of Pharmacoeconomics & Outcomes Research
      PubDate: 2022-08-03T12:02:54Z
      DOI: 10.1080/14737167.2022.2107507
       
  • Trastuzumab biosimilar HLX02 versus reference trastuzumab in patients with
           recurrent or metastatic HER2-positive breast cancer: a model-based
           economic evaluation for China

    • Free pre-print version: Loading...

      Authors: Weishang Deng, Jia Hu, Mengting Li, Sensen Yang, Zeyu Xie, Jisheng Chen
      Pages: 1 - 10
      Abstract: .

      Citation: Expert Review of Pharmacoeconomics & Outcomes Research
      PubDate: 2022-08-03T11:04:31Z
      DOI: 10.1080/14737167.2022.2107506
       
  • Correction

    • Free pre-print version: Loading...

      Pages: 1 - 1
      Abstract: .

      Citation: Expert Review of Pharmacoeconomics & Outcomes Research
      PubDate: 2022-07-21T11:57:08Z
      DOI: 10.1080/14737167.2022.2101789
       
  • Mapping the FACT-G to EQ-5D-3L utility index in cancer with the Chinese
           values set

    • Free pre-print version: Loading...

      Authors: ZhiKui He, WenJie Liang, WenJia Xu, WenXiu Huang, XiaoMin Wang, KaiYong Huang, Li Yang
      Pages: 1 - 14
      Abstract: .

      Citation: Expert Review of Pharmacoeconomics & Outcomes Research
      PubDate: 2022-06-21T08:01:38Z
      DOI: 10.1080/14737167.2022.2091546
       
  • Budgetary impact analysis of alteplase - recombinant tissue plasminogen
           activator (rtPA) - as a thrombolytic treatment for acute ischemic stroke
           in Colombia

    • Free pre-print version: Loading...

      Authors: Yaneth Gil-Rojas, Pieralessandro Lasalvia
      Pages: 1 - 8
      Abstract: .

      Citation: Expert Review of Pharmacoeconomics & Outcomes Research
      PubDate: 2022-06-16T09:05:31Z
      DOI: 10.1080/14737167.2022.2089655
       
  • Hyperbaric oxygen therapy as an adjunct to the standard wound care for the
           treatment of diabetic foot ulcers in Indian patients: a cost utility
           analysis

    • Free pre-print version: Loading...

      Authors: Friji Meethale Thiruvoth, Subramania Raju Rajasulochana, Mathan Kumar S, Saravanan E, Parthibane Sivanantham, Sitanshu Sekhar Kar
      Pages: 1 - 8
      Abstract: .

      Citation: Expert Review of Pharmacoeconomics & Outcomes Research
      PubDate: 2022-06-10T05:32:35Z
      DOI: 10.1080/14737167.2022.2085562
       
  • Gap analysis in manufacturing, innovation and marketing of medical devices
           in the Asia-Pacific region

    • Free pre-print version: Loading...

      Authors: Binaya Sapkota, Subish Palaian, Sunil Shrestha, Akihiko Ozaki, Mohamed Izham Mohamed Ibrahim, Mihajlo Jakovljevic
      Pages: 1 - 8
      Abstract: .

      Citation: Expert Review of Pharmacoeconomics & Outcomes Research
      PubDate: 2022-06-08T03:03:45Z
      DOI: 10.1080/14737167.2022.2086122
       
  • Examining the correlation between treatment effects in clinical trials and
           economic modeling

    • Free pre-print version: Loading...

      Authors: Xuanqian Xie, Myra Wang, Olga Gajic-Veljanoski, Chenglin Ye, Daniel M. Blumberger, Andrei Volodin
      Pages: 1 - 8
      Abstract: .

      Citation: Expert Review of Pharmacoeconomics & Outcomes Research
      PubDate: 2022-06-06T04:36:19Z
      DOI: 10.1080/14737167.2022.2079497
       
  • A review of caregiver costs included in cost-of-illness studies
         This is an Open Access Article Open Access Article

    • Free pre-print version: Loading...

      Authors: T. Joseph Mattingly, Valeria Diaz Fernandez, Dominique Seo, Andrea I. Melgar Castillo
      Pages: 1 - 10
      Abstract: .

      Citation: Expert Review of Pharmacoeconomics & Outcomes Research
      PubDate: 2022-06-02T08:08:18Z
      DOI: 10.1080/14737167.2022.2080056
       
  • Cost-effectiveness analysis of donafenib versus lenvatinib for first-line
           treatment of unresectable or metastatic hepatocellular carcinoma

    • Free pre-print version: Loading...

      Authors: Rui Meng, Xueke Zhang, Ting Zhou, Mengjie Luo, Yijin Qiu
      Pages: 1 - 8
      Abstract: .

      Citation: Expert Review of Pharmacoeconomics & Outcomes Research
      PubDate: 2022-05-26T07:12:04Z
      DOI: 10.1080/14737167.2022.2079498
       
  • Cost-effectiveness analysis of molecular diagnosis by next-generation
           sequencing versus sequential single testing in metastatic non-small cell
           lung cancer patients from a south Spanish hospital perspective

         This is an Open Access Article Open Access Article

    • Free pre-print version: Loading...

      Authors: Enrique de Alava, María Jesús Pareja, David Carcedo, Natalia Arrabal, José-Francisco García, Reyes Bernabé-Caro
      Pages: 1 - 10
      Abstract: .

      Citation: Expert Review of Pharmacoeconomics & Outcomes Research
      PubDate: 2022-05-26T06:48:19Z
      DOI: 10.1080/14737167.2022.2078310
       
  • Predicting key drivers for health care expenditure growth in the Middle
           East region: a Grossman-PLS modeling approach

    • Free pre-print version: Loading...

      Authors: Muhammad Muazu Bala, Shailender Singh, Nishant Kumar, Hawati Janor
      Pages: 1 - 11
      Abstract: .

      Citation: Expert Review of Pharmacoeconomics & Outcomes Research
      PubDate: 2022-05-16T08:26:44Z
      DOI: 10.1080/14737167.2022.2073222
       
  • Financial evaluation of value-creating biosimilar development candidates:
           a business case study of low-, medium- and high-sales biosimilars

    • Free pre-print version: Loading...

      Authors: Ronak Patel, Tulip Nuwal
      Pages: 1 - 19
      Abstract: .

      Citation: Expert Review of Pharmacoeconomics & Outcomes Research
      PubDate: 2022-05-12T01:25:03Z
      DOI: 10.1080/14737167.2022.2072830
       
  • Direct medical and indirect absenteeism costs among working adult ADHD
           patients in the United States

    • Free pre-print version: Loading...

      Authors: Chintal H. Shah, Eberechukwu Onukwugha
      Pages: 1 - 8
      Abstract: .

      Citation: Expert Review of Pharmacoeconomics & Outcomes Research
      PubDate: 2022-05-11T07:30:13Z
      DOI: 10.1080/14737167.2022.2073223
       
  • Summary of the 2020 AHRQ research meeting on ‘advancing methods of
           implementing and evaluating patient experience improvement using consumer
           assessment of healthcare providers and systems (CAHPS®) surveys’

    • Free pre-print version: Loading...

      Authors: Denise Quigley, Nabeel Qureshi, Lise Rybowski, Dale Shaller, Susan Edgman-Levitan, Paul D. Cleary, Caren Ginsberg, Ron D. Hays
      Pages: 1 - 8
      Abstract: .

      Citation: Expert Review of Pharmacoeconomics & Outcomes Research
      PubDate: 2022-05-05T08:17:00Z
      DOI: 10.1080/14737167.2022.2064848
       
  • Use of the incremental cost-effectiveness ratio for decision-making
           policies—what is the problem' A perspective paper

    • Free pre-print version: Loading...

      Authors: Matthew Brougham, Michael Schlander, Harry Telser, Sumeet Bakshi, Oriol Sola-Morales
      Pages: 1 - 6
      Abstract: .

      Citation: Expert Review of Pharmacoeconomics & Outcomes Research
      PubDate: 2022-05-05T01:49:41Z
      DOI: 10.1080/14737167.2022.2064847
       
  • Prescription drug coverage satisfaction and medication nonadherence among
           Medicare beneficiaries with cancer

    • Free pre-print version: Loading...

      Authors: Ciara Silverman, Boon Peng Ng, Chaewon Baek, Chanhyun Park
      Pages: 1 - 9
      Abstract: .

      Citation: Expert Review of Pharmacoeconomics & Outcomes Research
      PubDate: 2022-04-29T07:10:49Z
      DOI: 10.1080/14737167.2022.2064846
       
  • Effects of utilization management on health outcomes: evidence from
           urinary tract infections and community-acquired pneumonia

    • Free pre-print version: Loading...

      Authors: Martin Andersen, Anurag Pant
      Pages: 1 - 12
      Abstract: .

      Citation: Expert Review of Pharmacoeconomics & Outcomes Research
      PubDate: 2022-04-27T11:48:23Z
      DOI: 10.1080/14737167.2022.2067529
       
  • Assessing the value contribution of bimekizumab for the treatment of
           moderate-to-severe psoriasis using a multidisciplinary reflective
           multi-criteria decision analysis

         This is an Open Access Article Open Access Article

    • Free pre-print version: Loading...

      Authors: Néboa Zozaya, Fernando Abdalla, Santiago Alfonso Zamora, Jesús Balea Filgueiras, José Manuel Carrascosa Carrillo, Olga Delgado Sánchez, Francisco Dolz Sinisterra, Antonio García-Ruiz, Pedro Herranz Pinto, Antonio Manfredi, José Martínez Olmos, Paloma Morales de Los Ríos Luna, Lluis Puig, Sandra Ros, Álvaro HIdalgo-Vega
      Pages: 1 - 13
      Abstract: .

      Citation: Expert Review of Pharmacoeconomics & Outcomes Research
      PubDate: 2022-04-25T04:26:16Z
      DOI: 10.1080/14737167.2022.2063842
       
  • A landscape analysis and discussion of value of gene therapies for sickle
           cell disease

    • Free pre-print version: Loading...

      Authors: D Quach, B Jiao, a Basu, Ma Bender, Js Hankins, Sd Ramsey, B Devine
      Pages: 1 - 21
      Abstract: .

      Citation: Expert Review of Pharmacoeconomics & Outcomes Research
      PubDate: 2022-04-19T06:48:51Z
      DOI: 10.1080/14737167.2022.2060823
       
  • Adoption of new therapies in the treatment of Hepatitis: a verification of
           the accuracy of budget impact analysis to guide investment decisions

    • Free pre-print version: Loading...

      Authors: Daniel Resende Faleiros, Everton Nunes da Silva, Andreia C Santos, Brian B. Godman, Ramon Goncalves Pereira, Augusto A Guerra Junior
      Pages: 1 - 13
      Abstract: .

      Citation: Expert Review of Pharmacoeconomics & Outcomes Research
      PubDate: 2022-04-04T10:30:51Z
      DOI: 10.1080/14737167.2022.2057950
       
  • Burden of illness the first year after diagnosed bladder dysfunction among
           people with spinal cord injury or multiple sclerosis – a Danish register
           study

    • Free pre-print version: Loading...

      Authors: Marie Lynge Buchter, Jakob Kjellberg, Rikke Ibsen, Catarina Sternhufvud, Birte Petersen
      Pages: 1 - 8
      Abstract: .

      Citation: Expert Review of Pharmacoeconomics & Outcomes Research
      PubDate: 2022-03-28T04:52:21Z
      DOI: 10.1080/14737167.2022.2054804
       
  • Cost-effectiveness of dapagliflozin compared to DPP-4 inhibitors as
           combination therapy with metformin in the treatment of type 2 diabetes
           mellitus without established cardiovascular disease in Colombia

    • Free pre-print version: Loading...

      Authors: Pieralessandro Lasalvia, Yaneth Gil-Rojas, Ángel García
      Pages: 1 - 10
      Abstract: .

      Citation: Expert Review of Pharmacoeconomics & Outcomes Research
      PubDate: 2022-03-08T05:50:56Z
      DOI: 10.1080/14737167.2022.2044310
       
  • Hospital incidence and medical costs of polycythemia vera in Spain: a
           retrospective database analysis

    • Free pre-print version: Loading...

      Authors: Josep Darbà, Alicia Marsà
      Pages: 1 - 6
      Abstract: .

      Citation: Expert Review of Pharmacoeconomics & Outcomes Research
      PubDate: 2022-02-21T11:04:37Z
      DOI: 10.1080/14737167.2022.2029413
       
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
 


Your IP address: 18.204.56.97
 
Home (Search)
API
About JournalTOCs
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-